Mobilized peripheral blood (mPB) is a prevalent source of hematopoietic progenitors for transplantation; however, allogeneic and haploidentical transplants are often accompanied by severe GVHD. Following the observation that murine GVHD is ameliorated by pretransplant donor cell exposure to Fas-ligand (FasL) without host-specific sensitization, we assessed the susceptibility of mPB cells to spontaneous and receptor-induced apoptosis as a possible approach to GVHD prophylaxis. Short incubation for 4 h resulted in spontaneous apoptosis of 50% of the T and B lymphocytes and 60% myeloid cells. Although expression of Fas and TNF-R1 was proportionate to fractional apoptosis, cell death was dominated by spontaneous apoptosis. Functional assays revealed that the death receptors modulated mPB graft composition as compared with incubation in medium, without detectable quantitative variations. Removal of dead cells increased the frequency of mPB myeloid progenitors (Po0.001 vs medium), and recipients of mPB exposed to death ligands displayed reduced GVHD (Po0.01 vs medium) and improved survival following lipopolysacharide stimulation. mPB grafts exposed to the apoptotic challenge retained SCID reconstituting potential and graft versus tumor activity. These data emphasize that short-term exposure of mPB grafts to an apoptotic challenge is effective in reduction of GVHD effector activity.
INTRODUCTION
Transplantation of hematopoietic stem and progenitor cells is a common rescue procedure with significant immunotherapeutic efficacy in oncology, which is being investigated for the treatment of nononcological disorders. Nonmyeloablative and reduced intensity conditioning have reduced significantly the mortality and morbidity associated with hematopoietic stem and progenitor cell transplants; however, several major obstacles are yet to be overcome toward wide therapeutic implementation of this modality. One of the prevalent sources of donor cells is collection of hematopoietic progenitors by pheresis following mobilization into the peripheral circulation. This graft collecting procedure often includes relatively large numbers of mature T cells with dual activity in hematopoietic transplants. 1, 2 On the one hand donor T cells facilitate progenitor engraftment and function, and complete depletion of these cells might result in graft failure and relapse of the malignancy. On the other hand, mature donor T cells mediate GVHD, a severe complication with potentially lethal outcome.
As removal of all T cells eliminates their engraftment-facilitating activity, more selective depletion approaches to GVHD prophylaxis have been evaluated. Some approaches modulate the donor T-cell inoculum by inactivation and/or induction of apoptosis in T cells using radiation, photoactivation of psoralen and cytotoxic agents. [3] [4] [5] [6] [7] Other studies use host-specific sensitization for activation and selective elimination of alloreactive donor cells using cytotoxic agents, fusion proteins and activation-induced cell death (AICD). [8] [9] [10] [11] [12] [13] Deletion of host-sensitized T cells is effectively achieved by simulation of the physiological AICD mechanisms through cross-linking of the Fas receptor. [8] [9] [10] [11] We have recently reported that selective sensitization to host Ags is dispensable, and a short apoptotic challenge ex vivo is equally effective in reducing GvH effector propensity in murine hematopoietic cell grafts. 14 Importantly, both approaches of Fas-mediated deletion of host-primed and unsensitized donor T cells preserved antiviral and graft versus tumor (GVT) activities. 10, 11, 14 Apoptosis-based functional deletion of T cells might prove itself an effective approach to GVHD prophylaxis because murine and human hematopoietic progenitors are largely insensitive to apoptotic signaling through the TNF family receptors. [15] [16] [17] [18] [19] On the contrary, the dual activity of TNF family receptors includes trophic signaling in murine and human progenitors and apoptotic signaling in the differentiated progeny, which acquires sensitivity to AICD during maturation and activation. [16] [17] [18] [19] Polarized sensitivities of murine BM-derived progenitors and T cells to apoptosis might obviate isolation of T cells for negative selection, making the procedure short and simple in the absence of sensitization to host Ags.
14 In this study, we aimed to validate the murine data in cryopreserved mobilized peripheral blood (mPB) samples, as validated for ex vivo sensitization and depletion.
(IRB file 3656: 920050264). The frozen cell samples were collected by mobilization with G-CSF and preserved as backup in case of failure of engraftment. All children were in complete remission following first relapse of hematopoietic malignancies and were planned for allogeneic hematopoietic cell transplant because of high risk of disease recurrence. Samples were cryopreserved for variable periods of time ranging from 2 to 4 years and were transferred to an anonymous collection of deceased patients. Thawed mPB samples contain B15% dead cells, which were eliminated by gradient centrifugation (1.077-1.08 g/mL, MP Biomedical, Illkirch, France). 18 
Apoptotic challenge
Cell suspensions (5 Â 10 6 cells/mL) were incubated for variable periods of time at 371 in 5% CO 2 in a humidified incubator in medium and with supplementation of either FLAG-tagged FasL (Axxora, Farmingdale, NY, USA) or 20 ng/mL recombinant TNF-a (PeproTech, Rocky Hill, NJ, USA). Human cells were incubated in minimum essential medium-a (a-MEM) culture medium (Biological Industries, Beit Haemek, Israel) supplemented with StemPro Nutrient Supplement (Stem Cell Technologies, Vancouver, BC, Canada), 2 mM L-glutamine and 50 mM 2b-Mercaptoethanol purchased from PeproTech. 18 Dead cells were eliminated by centrifugation over a Ficoll gradient (MP Biomedical). T cells were stimulated with beads conjugated to anti-CD3 and anti-CD28 (Invitrogen, Oslo, Norway) at a bead:cell ratio of 1:1. 20 
Flow cytometry
Measurements were performed with a Vantage SE-2 flow cytometer (Becton Dickinson, Franklin Lakes, NJ, USA). CD34 þ cells were identified using APC-labeled Abs (clone 8G12, Pharmingen, San Diego, CA, USA), and lineages were quantified using PE-labeled MoAb: anti-human CD3 (clone OKT3, Pharmingen), anti-human CD19 (clone HD37, IQProducts, Groningen, The Netherlands) and anti-human CD33 (clone WM53, IQProducts). 18 T cells were immunophenotyped using Abs against CD4 (clone RPA-T4), CD8 (clone RPA-T8), CD25 (clone 7D4) and CD69 (clone FN50, Pharmingen and eBioscience, San Diego, CA, USA). Expression of the receptors was determined using MoAbs against human Fas (clone DX2, Miltenyi Biotec), TNF-R1 and TNF-R2 (clones 16803 and 22235 respectively, R&D Systems, Abingdon, UK). 19 Cell death and apoptosis were determined in cells incubated with 5 mg/mL 7-aminoactinomycin-D (7-AAD, Sigma, St Louis, MO, USA) and Annexin-V (IQ Products), respectively. 18 Engraftment of mPB cells in NOD.SCID xenochimeras was determined in the BM after 12 weeks using Abs against murine CD45 (clone 30-F11, eBioscience) and human CD45 (clone ML2, IQ Products). 17 Cell cycling was determined with an intracellular dye loaded by incubation for 7 min with 5 mM of (5-and 6-)carboxyfluorescein diacetate succinimidyl ester (CFSE; Molecular Probes, Eugene, OR, USA). Proliferation index was quantified with the ModFit software (Verity Software House, Topsham, ME, USA).
Colony-forming unit assays CFU assays were performed by plating 2.5 Â 10 3 mononuclear cells per well in 0.9% methylcellulose containing Iscove Modified Dulbecco Medium (Biological Industries) supplemented with 2 mM L-glutamine, 30% FCS, and 50 ng/mL SCF, 10 ng/mL IL-3 and 10 ng/mL recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF, PeproTech). 18 
Animal model and transplantation
Mice used in this study were NOD.CB17-Prkdc scid (NOD.SCID, H2K g7 ) purchased from Jackson Laboratories (Bar Harbor, ME, USA) and housed in a barrier facility in accordance with the guidelines of the Institutional Animal Care and Use Committee. NOD.SCID mice were conditioned with two consecutive daily doses of 25 mg/g busulfan (BU). 18 A series of calibration experiments were performed to establish the numbers of mPB cells required to induce sublethal GVHD in the xenochimeric model. Clinical GVHD was scored according to normal (0) and abnormal (1) parameters: (a) skin disease and hair loss, (b) weakness, (c) footpad hyperkeratosis and (d) diarrhea. 14, 21 In some experiments NOD.SCID mice grafted with mPB cells were administered 10 mg lipopolysacharide to induce lethal GVHD. 10, 13 Readouts and clinical GVHD grading were performed by trained technicians and were blinded for the different experimental arms. Preliminary studies showed that survival does not change after 4 weeks post-transplant; therefore, this time was chosen for end point analysis. HT29 human colon carcinoma cells (ATCC, Manassas, VA, USA) were implanted subcutaneously (5 Â 10 6 ) into the flank of 6-to 8-week old NOD.SCID mice, and tumor size (mm 3 ) was determined using a caliper according to (length Â width 2 Â 0.4). 22 In a second model, 10
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Jurkat cells were infused into NOD.SCID mice.
Histology
The liver and skin were collected from mice euthanized by CO 2 asphyxiation and were fixed in ice-cold PBS containing 1.5% fresh paraformaldehyde for 2 h at 0-4 1C before overnight immersion in 30% sucrose. 13, 14 Tissues were embedded in OCT (Sakura Finetek, Torrance, CA, USA), frozen in isopentane suspended in liquid nitrogen, sectioned (3-6 mm) with a Cryotome (Thermo Shandon, Cheshire, UK) and stained with hematoxylin and eosin. Samples were assessed using an Axioplan 2 (C. Zeiss, Gö ttingen, Germany) fluorescence microscope for injury scoring according to the following: 0-no infiltration, 1-scarce infiltrates, 2-patchy infiltration, 3-diffuse infiltration, 4-deterioration of tissue infrastructure.
Statistical analysis
Data are presented as means ± s.d. for each experimental protocol. Results in each experimental group were evaluated for reproducibility by linear regression of duplicate measurements. Differences between the experimental protocols were estimated with a post hoc Scheffe t-test, and significance was considered at Po0.05. Significant differences in survival were analyzed by the Mantel-Cox test.
RESULTS
Pretransplant exposure of mPB cells to death ligands ameliorates GVHD without impairing GVT Following removal of dead cells, thawed mPB samples were exposed for 4 h to toxic doses of FasL (50 ng/mL) and TNF-a (20 ng/mL) before transplantation into BU-conditioned NOD.SCID mice ( Figure 1a ). Recipients of mPB cells incubated in medium displayed severe GVHD as determined from weight loss (Figure 1b 1e). Despite relative resistance of the SCID xenogeneic model to lethal GVHD, inflammation was markedly reduced by short incubation (4 h) of the mPB grafts with death ligands without host-specific sensitization. Superior xenochimeric mouse survival of a lipopolysacharide challenge was also observed in recipients of FasL-pretreated cells from two fresh peripheral blood samples obtained from healthy donors (experiments currently underway), indicating that GVHD amelioration is associated primarily with the activity of the receptors rather than susceptibility of cryopreserved-thawed samples to apoptosis.
Effective abrogation of GVHD through fractional depletion of apoptosis-sensitive T cells questions the potency of GVT reactions. We used a human colon carcinoma cell line HT29 implanted subcutaneously in NOD.SCID mice to evaluate the impact of human mPB-derived lymphocytes. Infusion of 3 Â 10 7 mPB cells preincubated in medium and with FasL ( Figure 1f ) and TNF-a (not shown) caused similar suppression of tumor growth (Po0.001 vs unmanipulated mice). Similar sustained GVT activity was observed following infusion of Jurkat lymphoblastoma cells; however, evaluation of survival was difficult to interpret due to different intensities of concurrent GVHD in the various protocols. The numbers of nodules on the lung surface on day þ 40 were reduced by infusion of naïve (14±5) and FasL-pretreated mPB lymphocytes (16 ± 4) (Po0.05, vs 23 ± 7 in untreated mice). These data corroborate the persistent GVT reactivity of murine lymphocytes following treatment with FasL with and without host-specific stimulation.
Sensitivities of mPB cells to apoptosis
To characterize the impact of the death ligands on mPB cells, we assessed the responsiveness and apoptotic signaling mediated by the receptors. After removal of dead cells, the thawed mPB samples included o10% dead cells, with dominant (60%) viable fractions of myeloid cells and B20% T and B lymphocytes. Apoptosis was measured by gating on the various subsets in mixed mPB cultures (Figure 2a) . 23 Incubation of the thawed cells for 4 h showed balanced apoptosis of B and T lymphocytes and increased mortality of myeloid cells (Figure 2b ). Extending the incubation period increased fractional apoptosis of all lineagepositive subsets, with more accentuated apoptosis of B as compared with T lymphocytes (Figure 2c ). The two incubation time points shared several common characteristics. First, both time points were characterized by relatively low levels of apoptosis of CD34 þ progenitors as opposed to high mortality rates of lineage-positive subsets. Second, the various lineages displayed differential sensitivities to apoptosis, with excessive death of myeloid cells and relatively better survival of T cells. Limited information collected on fresh mPB samples (two with FasL and one with TNF-a) showed similar relative susceptibilities of the various lineage-positive subsets to apoptosis (not shown). The composition of viable cells after incubation mirrored the susceptibilities of the various subsets to death in short-term culture (Figure 3d) . Third, the minimal influence of the death ligands on fractional apoptosis indicates that susceptibility to spontaneous apoptosis in culture was the primary and major cause of cell death. These data disclose absolute numbers of T cells grafted after 4 and 16 h of incubation in the order of 3.8±0.3 Â 10 8 live cells per kilogram, without significant variations following incubation with the death ligands.
Expression of Fas and TNF-a receptors
The responsiveness of various mPB lineages to the death ligands is determined by expression of the cognate receptors (Figure 3a) . TNF-R2 was expressed at low levels in all lineages, a receptor that has poor apoptotic and trophic activity in hematopoietic progenitors. 19 However, the Fas and TNF-R1 receptors associated with transduction of apoptotic signals were detected in significant fractions of lineage-positive mPB cells. CD34 þ progenitors characterized by good survival presented Fas expression in B25% of the cells, accompanied by lower levels of TNF-R1. In variance, similar levels of Fas and TNF-R1 were detected in all lineages: B35% of T cells, B55% of B lymphocytes and B65% of myeloid cells. Expression of Fas and TNF-R1 was largely proportionate but less than fractional apoptosis (Figure 2b ), suggesting that these receptors were more prevalent in cells susceptible to spontaneous apoptosis in culture.
Sensitivities of T cells to apoptosis Effective amelioration of GVHD by short exposure to an apoptotic challenge was attained with modest quantitative differences between cells incubated with and without the death ligands. Therefore, the immune reaction might have been modulated by variations in T-cell subsets and/or qualitative attenuation of T-cell contents in the grafts under the influence of FasL and TNF-a. We assessed several parameters of T cells in mPB samples exposed to the death ligands as compared with medium. At similar levels of fractional T-cell apoptosis, the CD8 þ subset was modestly induced into apoptosis by the death ligands (Po0.05), whereas the CD4 þ subset showed balanced viability in all culture conditions (Figure 3b ). Extended culture was evidently associated with increased factional apoptosis of both CD25
À /low naïve/effector and CD25 high regulatory subsets (Figure 3c) . Notably, 485% of regulatory T cells characterized by high levels of CD25 co-express the transcription factor FoxP3. 23 The most significant modulation of T cells was reduced expression of the activation markers CD25 and CD69 in live cells following incubation with both ligands (Figure 3d ). Reduced propensity of CD69 in CD4 þ T cells was caused by excessive apoptosis of cells expressing this activation marker. Therefore, amelioration of GVHD severity by an apoptotic challenge was not caused by depletion of particular T-cell subsets, but rather decreased contents of activated T cells within the mPB grafts. Despite reduced contents of activated cells, the proliferative responses of T cells to CD3/CD28 ligation were preserved following incubation with the death ligands (3.75±0.32 with both ligands vs 4.3±0.25 in medium, Figure 3e ), substantiating the capacity of residual naive T cells to elicit potent GVT reactions.
Ex vivo exposure to death ligands does not impair SRC activity and progenitor function Polarized sensitivity to apoptosis of CD34 þ progenitors and lineage-positive subsets suggests that the apoptotic challenge can be applied to enrich progenitors. mPB units were exposed to toxic doses of FasL and TNF-a for 4 and 16 h, and equal numbers of viable cells were plated in semisolid cultures following removal of dead cells by gradient centrifugation (Figure 4a ). Incubation for 16 h resulted in increased frequencies of colony-forming units apoptosis with and without the death ligands, equal numbers of viable mPB cells were grafted into BU-conditioned NOD.SCID mice. All mice displayed similar levels of human cell chimerism in the BM at 12 weeks following transplantation of thawed and incubated mPB cells with and without the death ligands (Figure 4c ). These data demonstrate that 16 h of incubation was not detrimental to SRC activity, as expected from the good survival of CD34 þ progenitors. Both functional assays demonstrate resistance of mPB-derived SRC and colony-forming units to apoptosis mediated by the Fas and TNF receptors.
DISCUSSION
Allogeneic and haploidentical transplants of mPB cells are associated with severe and potentially lethal GVHD, due to significant contamination of the graft with mature donor T cells. Sensitization to host Ags and selective elimination of activated cells using apoptotic signals have been effective in amelioration of GVHD mediated by murine and human T cells. 10, 11 In this study, we demonstrate that like murine BM cells, 14 an apoptotic challenge without host-selective sensitization reduces GvH reactivity of mPB grafts. Resistance of hematopoietic progenitors to apoptotic signaling obviates complex procedures of T-cell isolation and depletion of apoptosis-sensitive subsets enriches the resistant progenitors, reducing significantly the complexity of graft preparation.
Hematopoietic progenitors in thawed mPB samples survive short-term culture without supporting chemokines, similar to the conditions of graft preparation in the clinical setting. Insensitivity of progenitors to apoptosis mediated by Fas, TNF and TRAIL receptors is a common functional characteristic observed in murine BM, [15] [16] [17] [18] human UCB and mPB cells. 18, 19 Mobilized PB cells are potentially responsive to signaling through TNF family receptors including 25% of thawed CD34 þ progenitors expressing Fas; however, the majority survived cross-linking of this receptor. The outstanding progenitor endurance is likely associated with overexpression of a series of anti-apoptotic factors including Bcl-2, FLICE inhibitory protein (FLIP), inhibitor of apoptosis proteins (IAP) and nuclear factor-kB (NFkB). [24] [25] [26] [27] [28] Survival of progenitors was emphasized in this study by unperturbed activities of SCID-repopulating cells and committed myeloid precursors following exposure of mPB cells to apoptotic signals for 16 h in liquid culture. Relative insensitivity of progenitors to spontaneous and receptor-mediated apoptosis is the basis for two potentially useful applications of graft preparation for transplantation.
Incubation of thawed mPB samples in medium and with the ligands increased the activity of viable cells in semisolid cultures, indicating that excessive death of lineage-positive subsets increases progenitor frequency. The dominant cause of lineage-positive cell death in culture was spontaneous apoptosis, which exceeded the levels of expression of Fas and TNF-R1. Therefore, the apparently proportionate variations in receptor expression and fractional death indicate that these receptors were more prevalent in apoptosis-susceptible cells. Increased CFU activity was most significantly affected by death of myeloid cells and B lymphocytes, which exceeded the levels of fractional apoptosis of T cells. Progenitor enrichment was not evident after short incubation (4 h) despite significant death of 50% T and B lymphocytes and two-thirds of myeloid cells. Although incorporation of Annexin-V delineated apoptosis, the period of incubation was insufficient for acquisition of the morphological features required for sedimentation of dead cells by density gradient centrifugation. It is important to minimize the duration of the ex vivo incubation period because the phenotype and function of mPB cells change rapidly and are associated with significant reduction in engraftment potential.
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The most significant outcome of the proposed approach to graft preparation was marked reduction in GVHD severity, as demonstrated for cryopreserved and validated in fresh mPB samples. As an inflammatory reaction mediated by mature donor T cells, GVHD is easier to prevent by functional depletion of heterogeneous T-cell subsets [3] [4] [5] [6] than elimination of distinct T-cell phenotypes.
1,2 The distinct advantage of functional over phenotypic T-cell depletion, as an approach to GVHD prophylaxis, is expected from the diverse and redundant molecular and cellular effectors of this reaction. [32] [33] [34] Administration of cytotoxic agents, such as immunotoxins, 13 cyclophosphamide 35, 36 and photoactivated cytotoxic agents, 37, 38 early after mutual donorhost sensitization ameliorates GVHD by selective killing of reactive donor T cells. The same approach to GVHD prophylaxis was applied by pretransplant treatment of the donors in vivo 39, 40 and exposure to host Ags ex vivo followed by elimination of stimulated T cells using cytotoxic agents, [3] [4] [5] [6] [7] 12 immunotoxins, 13, 41 anti-CD3 Abs 42 and AICD. [8] [9] [10] [11] Our approach obviates sensitization, which is the time consuming step in that approach and might allow evolution of memory effector cells insensitive to depletion that sustains persistent GvH reactivity. 14 As seen in previous murine studies, 14 the dominant consequence of the apoptotic challenge was qualitative rather than quantitative modulation of graft composition. The mechanism of GVHD prophylaxis relies on predominant deletion of cells expressing activation markers (CD25, CD69) at similar levels of T-cell depletion including the CD4 þ and CD8 þ subsets. Our findings are consistent with previous demonstration of GVHD amelioration by phenotypic depletion of T cells expressing these activation markers. [43] [44] [45] [46] [47] Effective GVHD prophylaxis was therefore achieved by elimination of T cells with effector potential through AICD, simulating the physiological mechanisms of negative regulation through apoptosis mediated by the TNF family receptors. 48 Such robust effect of pretransplant functional T-cell depletion was achieved because the grafted GVHD effectors expand in the target tissue and regional lymph nodes under lymphopenic conditions in response to alloantigen stimulation. 49 Exposure of the mPB grafts to death ligands caused commensurate depletion of regulatory T cell subsets, which are equally submitted to AICD-type negative regulation, 20 indicating that GVHD prophylaxis was primarily attained through reduced effector cell activity. This mechanism is consistent with the marked variations in survival following administration of lipopolysacharide, which precipitates lethal disease by induction of the cytokine storm. 10, 13, 14 Altogether, functional depletion of apoptosis-sensitive-activated T cells without exposure to host Ags evolves as an effective approach to reduce GvH reactivity of mature donor T cells. Importantly, residual T cells with reduced GVHD effector activity are beneficial to the outcome of transplants 1,2 through facilitation of progenitor engraftment, generation and potent GVT reactions and improved resistance to infections. [10] [11] [12] [13] [14] [39] [40] [41] [42] Mobilized progenitors collected from peripheral blood present several similar and distinct features as compared with UCB, which are apparently regulated at the transcriptional level. 50 The common feature is insensitivity of hematopoietic progenitors from both human sources to apoptosis mediated by the TNF family receptors, 18, 19 despite the fact that mPB progenitors were exposed to the potent myeloid differentiation signals of G-CSF in the process of mobilization. The most prominent difference is the lower incidence of progenitors in mPB as compared with UCB 51, 52 and less efficient expansion, 53 likely due to faster progression in cell cycling phases 54 and proliferation of the former. 55 All mPB lineages are generally more susceptible to apoptosis than UCB cells in culture, and T cells display the most pronounced difference. Activated lymphocytes in peripheral circulation are sensitive to spontaneous and receptor-induced apoptosis, whereas naive UCB T cells retain viability in culture. 19 In summary, polarized susceptibility to apoptosis of progenitors and T cells is useful in preparation of hematopoietic grafts, a functional approach that mediates two simultaneous activities. First, selective death of lineage-positive cells enriches progenitors without affecting the activity of more primitive precursors such as SCID-repopulating cells. Functional deletion of T cells by apoptosis recapitulates the physiological AICD process and is markedly superior to indiscriminate phenotypic elimination of donor T cells from the graft. Residual donor T cells have a significant role in support and facilitation of progenitor engraftment, 10, 14 reduce the threat of infections and generate potent GVT reactions. 11, 56 Second, pretransplant activation of TNF family receptors, including Fas, TNF-R1 and TRAIL-R1 in human cells, mediates trophic signals that synergize with growth factors in induction of progenitor activity. [16] [17] [18] [19] The proposed approach to hematopoietic graft preparation by apoptosis is simple, reliable and effective, and removes the complexity of isolation and manipulation of various cell subsets. Significant efforts are invested in the development of new biomarkers to predict individual susceptibility to GVHD and identify donor-host pairs at risk, along early detection of GvH reactions after transplantation. [57] [58] [59] These new assays are expected to identify transplants in which more aggressive prophylactic measures should be applied and less immunosuppressive therapeutic measures should be administered in early stages of the reaction. 13, 60 
